Home/Filings/4/0001061983-26-000002
4//SEC Filing

Callos Andrew 4

Accession 0001061983-26-000002

CIK 0001061983other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 4:26 PM ET

Size

7.9 KB

Accession

0001061983-26-000002

Insider Transaction Report

Form 4
Period: 2026-01-05
Callos Andrew
EVP, Chief Commercial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2026-01-05$23.26/sh+15,000$348,90065,440 total
  • Sale

    Common Stock

    2026-01-05$60.28/sh15,000$904,20050,440 total
  • Exercise/Conversion

    Non-Qualified Stock Option (Right to Buy)

    2026-01-0515,00099,000 total
    Exercise: $23.26From: 2022-03-31Exp: 2031-03-31Common Stock (15,000 underlying)

Issuer

CYTOKINETICS INC

CIK 0001061983

Entity typeother

Related Parties

1
  • filerCIK 0001852129

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:26 PM ET
Size
7.9 KB